A case is presented of a 1-year-old Persian cat with a corneal sequestrum treated with a bidirectional corneoconjunctival transposition. The size of this lesion precluded use of a traditional corneoconjunctival transposition. At the time of writing, the patient maintained a clear visual axis with minimal scarring and no recurrence 6 months post-operatively. This report describes a novel surgical technique used to successfully treat a large feline corneal sequestrum. K E Y W O R D Sautograft, corneal sequestrum, corneoconjunctival transposition, feline, keratectomy, surgery

Background Injection techniques for retrobulbar anaesthesia are published in horses, but neither safety nor anaesthetic efficacy and duration have been evaluated objectively in vivo. Objective To characterise the safety and efficacy of one published technique for retrobulbar anaesthesia. Study design Randomised, controlled descriptive experiment. Methods Unilateral retrobulbar injection with 10 mL lidocaine (2%) was performed in eight sedated adult mares. Contralateral eyes served as untreated controls. Neurophthalmic parameters, intraocular pressure (IOP), and corneal and periocular sensation were measured awake, post‐sedation and at periodic time points for 24 hours following injection. Adverse effects were documented. Results Injection of 10 mL lidocaine significantly increased IOP for up to 2 hours (P < .05) maximally at 30 min (mean [95% CI]: 6.0 [2.7, 9.2] mm Hg, P < .001). Six of the eight treated eyes developed mild to moderate reversible chemosis for 2 to 24 hours. One eye developed severe chemosis and superficial corneal ulceration at 24 and 48 hours following injection respectively. Corneal sensitivity significantly decreased for 6 hours (P < .05), maximally at 10 min (−44.4 [−34.6, −54.1] mm, P < .001). Periocular sensitivity (measured as increase in applied force) significantly decreased dorsally and medially for up to 2 hours (maximal at 2 hours (367.1 [238.5, 495.7] g, P < .001, and at 30 min: 345.8 [202.6, 488.9] g, P < .001) respectively). Ventral and lateral sensitivity were not effectively decreased beyond 30 min. Optic nerve function was not consistently reduced following injection. Main limitations Investigators were not masked to the treated eye. Conclusions Retrobulbar injection using 10 mL lidocaine is safe in normal eyes of adult horses, but carries risk in structurally compromised or glaucomatous eyes due to transient IOP increase. Reversible chemosis commonly develops 2‐4h following injection, and may be severe in some horses with risk for corneal ulceration. Corneal anaesthesia is rapid and prolonged, but all periocular regions are not consistently anaesthetised. Retrobulbar injection should be combined with other local anaesthetic injections for eyelid surgeries or enucleations.

Objectives To evaluate the effect of QD or BID 0.02% netarsudil ophthalmic solution (Aerie Pharmaceuticals) on intraocular pressure (IOP) in normotensive dogs and to describe any adverse effects. Animals studied Normotensive Labrador retriever dogs were included in this study: 10 received netarsudil in one eye and artificial tears in the contralateral eye QD, and 10 received netarsudil in one eye and artificial tears in the contralateral eye BID. Procedures Intraocular pressure curves were acquired over a 3‐day acclimation period, 5‐day dosing period (QD or BID—10 dogs/group), and 3‐day recovery period. Toxicity was assessed daily using slit‐lamp biomicroscopy and the semiquantitative preclinical ocular toxicology scoring system. Results Once‐daily dosing did not lower IOP over the entire 5‐day dosing period (95% CI 0.1 to −0.9 mm Hg, P = .20) or on the last day of dosing (95% CI 0.4 to −0.9 mm Hg, P = .65). Twice‐daily dosing resulted in a statistically significant, but clinically unimportant, IOP reduction over the entire 5‐day dosing period (−0.6 mm Hg; 95% CI 0.05 to −1.1 mm Hg, P = .02) and on the last day of dosing (−0.9 mm Hg; 95% CI 0.2 to −1.5 mm Hg, P = .003). Adverse events were limited to transient mild‐to‐moderate conjunctival hyperemia during the dosing phase in eyes receiving netarsudil vs control (P < .0001). Conclusions Netarsudil 0.02% ophthalmic solution twice daily resulted in a small, statistically significant, but clinically unimportant, IOP reduction in normotensive dogs. Future studies should investigate efficacy in glaucomatous dogs.

Primary Objective To evaluate the effect of latex tip cover manufacturer on accuracy and repeatability of Tono‐Pen Vet™ in canine eyes. Animal Studied Twelve enucleated globes from six dogs. Procedures The anterior chamber was cannulated and connected to a calibrated manometer. Intraocular pressure (IOP) measurements were obtained using the Tono‐Pen Vet and TONOVET Plus at manometric IOP ranging from 5 to 80 mmHg. At each IOP, the Tono‐Pen Vet was used with a new Ocu‐Film™ latex tip cover (the only manufacturer‐approved brand of cover) followed by a new Softips™ latex tip cover. For comparison, the TONOVET Plus was also used at each IOP with a new disposable rebound probe. Measured IOP values were analyzed by linear regression and intraclass correlation coefficient (ICC). Results Tono‐Pen Vet accuracy was unaffected by tip cover manufacturer or by frequent change in cover. Using ICC analysis, repeatability of measurements using either tonometer was good to excellent at physiologic IOP levels but variably decreased with both devices at supraphysiologic IOP. Conclusions Neither tip cover manufacturer nor frequent changes in tip cover adversely affect Tono‐Pen Vet accuracy. Measurement repeatability with Tono‐Pen Vet and TONOVET Plus is widely variable at supraphysiologic IOP. Therefore, minor changes in IOP >25 mmHg should not be used to make clinical decisions without considering this variability.

No abstract